Glycogen Synthase Kinase (GSK) Inhibitors


Glycogen synthase kinase-3 (GSK-3), a multifunctional serine/ threonine kinase, is a key regulator of numerous signaling pathways. Two isoforms of GSK-3 are reported in mammals: a 51 kDα GSK-3α and a 47 kDa GSK-3β. GSK-3β is constitutively active in resting cells and treatment of cells with an agent, such as insulin, is shown to cause GSK-3 inactivation through a PI 3-kinase (PI 3-K)-dependent mechanism. PI 3-K-induced activation of PKB/Akt results in phosphorylation of Ser21 on GSK-3α and Ser9 on GSK-3β, which inhibits GSK-3 activity. The phosphorylated N-terminus becomes a primed pseudosubstrate that occupies the positive binding pocket and the active site of the enzyme and acts as a competitive inhibitor for true substrates. This prevents phosphorylation of substrates. Arg96 is shown to be a crucial component of the positive pocket that binds primed substrates. Small molecule inhibitors that fit in the positively charged pocket of the kinase domain of GSK-3β are useful for selectively inhibiting primed substrates. Several known GSK-3 substrates participate in a wide spectrum of cellular processes, including glycogen metabolism, transcription, translation, cytoskeletal regulation, intracellular vesicular transport, cell cycle progression, and apoptosis. Phosphorylation of these substrates by GSK-3b usually has an inhibitory effect.

Abnormalities in pathways that use GSK-3 as a regulator have been linked to several disease conditions. Hence, GSK-3 has emerged as a potential therapeutic target, particularly in noninsulin- dependent diabetes mellitus, Alzheimer’s disease, developmental disorders, and cancer. Several new GSK-3 inhibitors have recently been developed, most of which act in an ATP competitive manner. Inhibitors belonging to aloisines, the paullones, and the maleimide families, have shown promise as therapeutic agents. Due to its involvement in multiple pathways, selectivity of GSK-3 inhibition is an important factor in the development of inhibitors for therapeutic applications.

Products in this category:
Catalog number Products
191500 1-Azakenpaullone - CAS 676596-65-9 - Calbiochem 
200980 Bikinin - CAS 188011-69-0 - Calbiochem 
217720 Cdk1/5 Inhibitor - CAS 40254-90-8 - Calbiochem 
344265 FRATtide 
361569 GSK-3beta Inhibitor XXVI - Calbiochem 
505767 GSK-3beta Inhibitor XXVII, CESI 
361540 GSK-3β Inhibitor I - CAS 327036-89-5 - Calbiochem 
361541 GSK-3β Inhibitor II - CAS 478482-75-6 - Calbiochem 
361566 GSK-3 Inhibitor IV, SB-216763 - CAS 280744-09-4 - Calbiochem 
361550 GSK-3 Inhibitor IX - CAS 667463-62-9 - Calbiochem 
 Pages  1 2 3 4 Next  
... or select the first letter of the product name

© Merck KGaA, Darmstadt, Germany, 2014


Welcome to Merck Millipore


Europe, Middle East and Africa Asia / Pacific North America, Central America and the Caribbean South America

Please choose your country:

North America, Central America and the Caribbean

South America

Europe, Middle East and Africa

Asia / Pacific

All countries from A to Z

If you can't find your country please click here.


Privacy Statement



Merck Chemicals Cart ()

You are entering the Millipore online shop. Both carts are maintained for you while you shop between sites. We recommend to complete your Merck order before visiting

Go to Millipore Proceed to checkout

What kind of products are you looking for?


Bio manufacturing and Life science.

Merck Chemicals

High-quality industrial and laboratory chemicals.

Important message

It is currently not possible to order Bioscience products together with other Merck products. We recommend completing your current order first.

Do you wish to proceed without completing your current order? If so, this will empty your shopping cart.